In this article, we argue that contemporary biomedicine is shaped by two, seemingly incommensurable, organizational logics, the ‘regime of truth’ and the ‘regime of hope’. We articulate their features by drawing on debates sparked by the recent clinical trial of a new approach to the treatment of Parkinson’s Disease. We also argue that the ‘self’ is configured in the very same process whereby these two organizational logics interlock and become mutually dependent, so that the ‘self’ might be said to be the effect of a ‘parasitic’ relationship between the regimes of ‘truth’ and ‘hope’. We then bring these two arguments to bear on the contrasting views of the relationship between embodiment and political subjectivity articulated by Michel Foucault and Giorgio Agamben, on the one hand, and Paul Rabinow and Nikolas Rose, on the other hand.
Agamben, G. (1998) Homo Sacer: Sovereign Power and Bare Life. Stanford, CA: Stanford University Press .
2.
Agamben, G. (1999a) ‘Une biopolitique mineure [A Minor Biopolitics]’ , Vacarme: http://vacarme.eu.org/article255.html (accessed 10 March 2005)
3.
Agamben, G. (1999b) Remnants of Auschwitz: The Witness and the Archive. New York: Zone Books .
4.
Agamben, G. (1999c) ‘Absolute Immanence’, in Potentialities: Collected Essays in Philosophy. Stanford, CA: Stanford University Press , pp. 220-239.
5.
Agamben, G. (2000) ‘Notes on Gesture’, in Means without End: Notes on Politics. Minneapolis: University of Minnesota Press , pp. 49-60.
6.
Albin, R. L. (2002) ‘Sham Surgery Controls: Intracerebral Grafting of Fetal Tissue for Parkinson’s Disease and Proposed Criteria for Use of Sham Surgery Controls’ , Journal of Medical Ethics28(5): 322-325 .
7.
Althusser, L. (1994) ‘Ideology and Ideological State Apparatus (Notes towards an Investigation)’, in S. Žižek (ed.) Mapping Ideology. London: Verso , pp. 100-140.
8.
Blue Cross/Blue Shield (2001) Embryonic Mesencephalic Transplantation for the Treatment of Parkinson’s Disease, TEC Assessment Program , Vol. 16, Report No. 8.
9.
Blue Cross/Blue Shield (2004) ‘TEC Criteria’: http://www.bcbs.com/tec/teccriteria.html (accessed 6 May 2004)
10.
Boer, G. J. (1999) ‘Ethical Issues in Neurografting of Human Embryonic Cells’ , Theoretical Medicine and Bioethics20: 461-475 .
11.
Boseley, S. (2001) ‘Parkinson’s Miracle Cure turns into a Catastrophe’ , Guardian, 13 March: http://www.guardian.co.uk/uk_news/story/0,3604,450981,00.html (accessed 6 May 2004)
12.
Bracco, L. (2002) ‘Pharmacogenomics and Personalized Medicine’ , Pharmacogenomics3(2): 166-171 .
13.
Breeze, R. E. and Wang, M. (1999) ‘An Overview of Central Nervous System Transplantation in Human Disease’ , Neurosurgical Focus7(3): 3-13 .
14.
Brown, N. (2003) ‘Hope against Hype: Accountability in Biopasts, Presents and Futures’ , Science Studies16(2): 3-21 .
15.
Brown, N. and Michael, M. (2003) ‘A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects’ , Technology Analysis and Strategic Management15(1): 3-18 .
16.
Brown, S. (2002) ‘Michel Serres: Science, Translation and the Logic of the Parasite’ , Theory, Culture & Society19(3): 1-27 .
17.
Brown, S. E. (1996) ‘Super Duper? The (Unfortunate) Ascendancy of Christopher Reeve’, http://www.independentliving.org/docs3/brown96c.html (accessed 9 March 2005)
18.
Callon, M. and Rabeharisoa, V. (2004) ‘Gino’s Lesson on Humanity: Genetics, Mutual Entanglements and the Sociologist’s Role’ , Economy and Society33(1): 1-27 .
19.
Caplan, A. (2003) ‘No-brainer: Can We Cope with the Ethical Ramifications of New Knowledge of the Human Brain?’, in S. J. Marcus (ed.) Neuroethics: Mapping the Field. New York: Dana Press , pp. 99-118.
20.
Cesaro, P. (2002) ‘Greffes neuronales et maladie de Parkinson [Neural Transplants and Parkinson’s Disease]’ , Revue Neurologique158(1): S142-S143 .
21.
Check, E. (2003) ‘Parkinson’s Transplant Therapy Faces Setback’ , Nature, 28 August: http://www.nature.com/nsu/030825-4.html (accessed 20 February 2004)
22.
Clemmit, M. (1992) ‘Fetal Tissue Research Uncertainties Foster Confusion among Many Bioscience Workers’ , The Scientist, 20 July: http://www.the-scientist.com/yr1992/jul/clemmitt_p1_920720.html (accessed 4 June 2004)
23.
Cussins, C. (1998) ‘Ontological Choreography: Agency for Women Patients in an Infertility Clinic’, in M. Berg and A. Mol (eds) Differences in Medicine: Unravelling Practices, Techniques, and Bodies. Durham, NC: Duke University Press , pp. 166-201.
24.
De Francesco, L. (2001) ‘Stem Cell Researchers take on Parkinson’s’ , The Scientist, 28 May: http://www.the-scientist.com/yr2001/may/research_010528.html (accessed 4 June 2004)
25.
Dehue, T. (2002) ‘A Dutch Treat: Randomized Controlled Experimentation and the Case of Heroin-maintenance in the Netherlands’ , History of the Human Sciences15(2): 75-98 .
26.
Dekkers, W. and Boer, G. (2001) ‘Sham Neurosurgery in Patients with Parkinson’s Disease: Is it Morally Acceptable?’ , Journal of Medical Ethics27(3): 151-156 .
27.
Deleuze, G. (1988) Foucault. Minneapolis: University of Minnesota Press .
28.
Dumit, J. (2004) Picturing Personhood: Brain Scans and Diagnostic Identity. Princeton, NJ: Princeton University Press .
29.
Epstein, S. (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley: University of California Press .
30.
Fink, J. S.et al. (2000) ‘Porcine Xenografts in Parkinson’s Disease and Huntington’s Disease Patients: Preliminary Results’ , Cell Transplants9(2): 273-278 .
31.
Foucault, M. (1970) The Order of Things. New York: Vintage Press .
32.
Foucault, M. (1990) History of Sexuality. Harmondsworth, Mx: Penguin .
33.
Foucault, M. (1991) ‘Politics and the Study of Discourse’, in G. Burchellet al. (eds) The Foucault Effect: Studies in Governmentality. London: Harvester Wheatsheaf , pp. 53-72.
34.
Foucault, M. (2000) ‘Questions of Method’, in J. C. [name at proof] (ed.) Michel Foucault: The Essential Works. London: Penguin , Vol. 3, pp. 223-238.
35.
Franzen, J. (2001) The Corrections. London: Fourth Estate .
36.
Freed, C. R.et al. (2001) ‘Transplantation of Embryonic Dopamine Neurons for Severe Parkinson’s Disease’ , New England Journal of Medicine344: 710-719 .
37.
Grisolía, J. S. (2002) ‘CNS Stem Cell Transplantation: Clinical and Ethical Perspectives’ , Brain Research Bulletin57(6): 823-826 .
38.
Haber, G. (2004) ‘Michael J. Fox Stumps at USF for Kerry’: http://news.tbo.com/news/MGB3W4NYOZD.html (accessed 9 March 2005)
39.
Hagell, P.et al. (2002) ‘Dyskinesias Following Neural Transplantation in Parkinson’s Disease’ , Nature Neuroscience5(7): 627-628 .
40.
Hagell, P. and Brundin, P. (2001) ‘Cell Survival and Clinical Outcome following Interstriatal Transplantation in Parkinson’s Disease’ , Journal of Neuropathology and Experimental Neurology60(8): 741-752 .
41.
Hornykiewicz, O. (2002) ‘L-DOPA: From a Biologically Inactive Amino Acid to a Successful Therapeutic Agent’ , Amino Acids23: 65-70 .
42.
Jullien, F. (2002) Un Sage est Sans Idée, ou l’Autre de la Philosophie [A Wise Man is Without Idea, or the Other of Philosophy]. Paris: Seuil .
43.
Keating, P. and Cambrosio, A. (2003) Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge, MA: MIT Press .
44.
King, J. (2000) ‘Christopher Reeve on Politics and Stem Cell Research’ , InsidePolitics, 30 July: http://edition.cnn.com/2001/ALLPOLITICS/07/29/reeve.cnna/ (accessed 5 July 2004)
45.
Kirschstein, R. and Skirboll, L. S. (2001) Stem Cells: Scientific Progress and Future Directions. Bethesda, MD: National Institutes of Health .
46.
Kolata, G. (2001) ‘Parkinson’s Research is set back by Failure of Fetal Cell Implants’ , New York Times, 8 March: http://www.nytimes.com/2001/03/08/.../08PARK.html (accessed 15 March 2001)
47.
Kopyov, O. V. , Jacques, D. , Lieberman, A. , Duma, C. M. and Rogers, R. L. (1996) ‘Clinical Study of Fetal Mesencephalic Intracerebral Transplants for the Treatment of Parkinson’s Disease’ , Cell Transplantation5(2): 327-337 .
48.
Kordower, J. H.et al. (1995) ‘Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson’s Disease’ , New England Journal of Medicine332(17): 1118-1124 .
49.
Law, J. (1994) Organizing Modernity. Oxford: Blackwell .
50.
Lindvall, O.et al. (1989) ‘Human Fetal Dopamine Neurons grafted into the Striatum in Two Patients with Severe Parkinson’s Disease. A Detailed Account of Methodology and a 6-Month Follow-up’ , Archives of Neurology46(6): 615-631 .
51.
Linke, D. B. (1993) Hirnverpflanzung: Die Neue Unsterblichkeit auf Erden [Brain Transplant: The New Immortality]. Hamburg: Rowohlt .
52.
Lock, M. (2002) Twice Dead: Organ Transplants and the Reinvention of Death. Berkeley: University of California Press .
53.
Marks, H. (1992) ‘Cortisone, 1949: A Year in the Political Life of a Drug’ , Bulletin of the History of Medicine66: 419-439 .
54.
Marks, H. (1997) The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990. Cambridge: Cambridge University Press .
55.
Marks, H. (2000) ‘Trust and Mistrust in the Marketplace: Statistics and Clinical Research, 1945-1960’ , History of Science38: 343-355 .
56.
McRae, C.et al. (2003) ‘Does Personality Change as a Result of Fetal Tissue Transplantation in the Brain?’ , Journal of Neurology250(3): 282-286 .
57.
Meek, J. (2001) ‘Stroke Tests go ahead despite US Warning’ , Guardian 16 April: http://www.guardian.co.uk/uk_news/story/0,3604,473707,00.html (accessed 6 May 2004)
58.
Mendez, I.et al. (2002) ‘Simultaneous Intrastriatal and Intranigral Fetal Dopinergenic Grafts in Patients with Parkinson’s Disease: A Pilot Study’ , Journal of Neurosurgery96(3): 589-596 .
59.
Moreira, T. (2004) ‘Knowledge Making in Systematic Reviews in Health Care: a Sociology of Data’ , paper presented at the ‘Health, Nature and Expertise’ workshop. Lisbon, 7-8 June.
60.
Moreira, T. (in press) ‘Mutual Parasitism in the Intra-operative Management of Blood Pressure’ , Social Studies of Science.
61.
Morrish, P. K. , Sawle, G. V. and Brooks, D. J. (1995) ‘Clinical and [18F] Dopa PET Findings in Early Parkinson’s Disease’ , Journal of Neurology, Neurosurgery and Psychiatry59(6): 597-600 .
62.
Mykhalovskyi, E. and Weir, L. (2004) ‘The Problem of Evidence-based Medicine: Directions for Social Science’ , Social Science and Medicine59: 1059-1069 .
63.
National Institute of Neurological Disorders and Stroke (2000) ‘Grants for Cell Implantation’, http://www.ninds.nih.gov/parkinsonsweb/grants_cell_implantation_2000.htm (accessed 23 July 2004)
64.
Nikkah, G. (2001) ‘Neural Transplantation Therapy for Parkinson’s Disease: Potential and Pitfalls’ , Brain Research Bulletin56(6): 509 .
65.
Northoff, G. (1996) ‘Do Brain Tissue Transplants alter Personal Identity? Inadequacies of Some “Standard” Arguments’ , Journal of Medical Ethics22: 174-180 .
66.
Olanow, C. W.et al. (2003) ‘A Double-blind Controlled Trial of Bilateral Fetal Nigral Transplantation in Parkinson’s Disease’ , Annals of Neurology54(3): 403-414 .
67.
Palladino, P. (2003) ‘Life... On Biology, Biography, and Bio-power in the Age of Genetic Engineering’ , Configurations11: 81-109 .
68.
Parkinson’s Disease Society (2004) ‘Frequently Asked Questions: What’s New in Parkinson’s Research?’http://www.parkinsons.org.uk/docs/viewdoc.asp?ID=114&catid=29&nodeid=224 (accessed 29 April 2004)
69.
Peschanski, M.et al. (1994) ‘Bilateral Motor Improvement and Alteration of L-dopa Effect in Two Patients with Parkinson’s Disease following Interstriatal Transplantation of Foetal Ventral Mesencephalon’ , Brain117(3): 487-499 .
70.
Petit-Zeman, S. (2001) ‘Trial and Error’ , Guardian 3 March: http://www.guardian.co.uk/health/story/0,3605,451999,00.html (accessed 30 April 2004)
71.
Piccini, P.et al. (1999) ‘Dopamine Release from Nigral Transplants visualised in vivo in a Parkinson’s Patient’ , Nature Neuroscience2(12): 1137-1140 .
72.
Polgar, S. , Morris, M. E. , Reilly, S. , Bilney, B. and Sanberg, P. R. (2003) ‘Reconstructive Neurosurgery for Parkinson’s Disease: a Systematic Review and Preliminary “Meta-analysis”’ , Brain Research Bulletin60: 1-24 .
73.
Pressman, J. D. (1998) Last Resort: Psychosurgery and the Limits of Medicine. Cambridge: Cambridge University Press .
74.
Price, L. H.et al. (1995) ‘Psychiatric Status after Human Fetal Mesencephalic Tissue Transplantation in Parkinson’s Disease’ , Biology and Psychiatry38(8): 498-505 .
75.
Prins, A. (1998) Aging and Expertise: Alzheimer’s Disease and the Medical Professions (1930-1990). Amsterdam: PhD Thesis, University of Amsterdam.
76.
Rabinow, P. (1996) ‘Artificiality and Enlightenment’, in Essays in the Anthropology of Reason. Princeton, NJ: Princeton University Press , pp. 91-111.
77.
Rabinow, P. (1999) French DNA: Trouble in Purgatory. Chicago, IL: University of Chicago Press .
78.
Rabinow, P. (2003) Anthropos Today: Reflections on Modern Equipment. Princeton, NJ: Princeton University Press .
79.
Rabinow, P. and Rose, N. (2003) ‘Thoughts on the Concept of Biopower Today’; http://www.yale.edu/afamstudies/Rabinow%2520and%2520Rose%2520-%2520Biopower%2520Today%25202003.pdf (accessed 6 July 2003)
80.
Ramachandran, A. C. , Bartlett, L. E. and Mendez, I. M. (2000) ‘A Multiple Target Neural Transplantation Strategy for Parkinson’s Disease’ , Review of Neurosciences13(3): 243-256 .
81.
Redmond, D. E. (2002) ‘Cellular Replacement Therapy for Parkinson’s Disease: Where are We Today?’ , Neuroscientist8(5): 457-488 .
82.
Remy, P.et al. (1995) ‘Clinical Correlates of [18F] Fluorodopa Uptake in Five Grafted Parkinsonian Patients’ , Annals of Neurology38(4): 580-588 .
83.
Rinne, J. O. , Ruottinen, H. , Bergman, J. , Haaparanta, M. , Sonninen, P. and Solin, O. (1999) ‘Usefulness of a Dopamine Transporter PET Ligand [(18)F] Beta-CFT in assessing Disability in Parkinson’s Disease’ , Journal of Neurology, Neurosurgery and Psychiatry67(6): 737-741 .
84.
Rose, N. (2001) ‘The Politics of Life Itself’ , Theory, Culture & Society18(6): 1-30 .
85.
Rose, N. (2003) ‘Becoming Neurochemical Selves’, in N. Stehr (ed.) Biotechnology between Commerce and Civil Society. Piscataway, NJ: Transaction Press , pp. 89-126.
86.
Rose, N. and Novas, C. (2000) ‘Genetic Risk and the Birth of the Somatic Individual’ , Economy and Society29: 485-513 .
87.
Sass, K. J.et al. (1995) ‘General Cognitive Ability following Unilateral and Bilateral Fetal Ventral Mesencephalic Tissue Transplantation for Treatment of Parkinson’s Disease’ , Archives of Neurology52(7): 680-686 .
88.
Sawle, G. V.et al. (1992) ‘Transplantation of Fetal Dopamine Neurons in Parkinson’s Disease: PET [18F]6-L-Fluoropdopa Studies in Two Patients with Putaminal Implants’ , Annals of Neurology31(2): 166-173 .
89.
Serres, M. (1982) The Parasite. Baltimore, MD: Johns Hopkins University Press .
90.
Smith, R. (1992) Inhibition: History and Meaning in the Sciences of Mind and Brain. London: Free Association Press .
91.
Spalding, B. J. (2000) ‘Nature’s Brain Specialist: Neural Stem Cell Research on the Rise’ , BioSpace.com 3 September: http://www.biospace.com/articles/030900_print.cfm (accessed 19 January 2001)
92.
Star, S. L. (1989) Regions of the Mind: Brain Research and the Quest for Scientific Certainty. Stanford, CA: Stanford University Press .
93.
Star, S. L. (1992) ‘The Skin, the Skull and the Self: Towards a Sociology of the Brain’, in A. Harrington (ed.) So Human a Brain: Knowledge and Values in the Neurosciences. Berlin: Birkhäuser , pp. 204-228.
94.
Storch, A. and Schwarz, J. (2002) ‘Neural Stem Cells and Parkinson’s Disease’ , Journal of Neurologysuppl. 3(3): 30-32 .
95.
Thévenot, L. (2001) ‘Pragmatic Regimes governing the Engagement with the World’, in K. Knorr-Cetina , T. Schatzki and E. von Savigny (eds) The Practice Turn in Contemporary Theory. London: Routledge , pp. 56-73.
96.
Timmermans, S. and Berg, M. (2003) The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Philadelphia, PA: Temple University Press .
97.
Valenstein, E. S. (1986) Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments of Mental Illness. New York: New York University Press .
98.
Žižek, S. (1999) The Ticklish Subject: The Absent Centre of Political Ontology. London: Verso .
